Differentially expressed gene (DEG) analysis, Kaplan-Meier analysis and Cox regression analysis helped us screen out Solute Carrier Family 25 Member 21 (SLC25A21) as an AML-specific prognostic marker. Here, SLC25A21 is linked to acute myeloid leukemia.